Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Landman

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
American Journal of Infection Control|March 31, 2015
Reduction in the prevalence of carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in New York CityMarie Abdallah, Olawole Olafisoye, Christopher Cortes, et al.
The Journal of Antimicrobial Chemotherapy|December 7, 2010
Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York CityDavid Landman, Paul Kelly, Martin Bäcker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2007
Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New YorkSimona Bratu, Steven Brooks, Sibte Burney, et al.
The Journal of Antimicrobial Chemotherapy|May 11, 2007
Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NYDavid Landman, Simona Bratu, Sandeep Kochar, et al.
Antimicrobial Agents and Chemotherapy|May 28, 2015
Activity of Imipenem with Relebactam against Gram-Negative Pathogens from New York CityAmabel Lapuebla, Marie Abdallah, Olawole Olafisoye, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2015
Activity of Meropenem Combined with RPX7009, a Novel β-Lactamase Inhibitor, against Gram-Negative Clinical Isolates in New York CityAmabel Lapuebla, Marie Abdallah, Olawole Olafisoye, et al.
Archives of Internal Medicine|June 29, 2005
Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentariumSimona Bratu, David Landman, Robin Haag, et al.
The Journal of Antimicrobial Chemotherapy|May 27, 2005
Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agentsSimona Bratu, Pooja Tolaney, Usha Karumudi, et al.
Infection Control and Hospital Epidemiology|November 19, 2020
Trends in central-line-associated bloodstream infections and catheter-associated urinary tract infections in a large acute-care hospital system in New York City, 2016-2019Monica A Kaminski, Briana Episcopia, Saquib Malik, et al.
The Journal of Antimicrobial Chemotherapy|March 2, 2012
Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustrationDavid Landman, Elizabeth Babu, Neha Shah, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
American Journal of Infection Control|March 31, 2015
Reduction in the prevalence of carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in New York CityMarie Abdallah, Olawole Olafisoye, Christopher Cortes, et al.
The Journal of Antimicrobial Chemotherapy|December 7, 2010
Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York CityDavid Landman, Paul Kelly, Martin Bäcker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2007
Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New YorkSimona Bratu, Steven Brooks, Sibte Burney, et al.
The Journal of Antimicrobial Chemotherapy|May 11, 2007
Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NYDavid Landman, Simona Bratu, Sandeep Kochar, et al.
Antimicrobial Agents and Chemotherapy|May 28, 2015
Activity of Imipenem with Relebactam against Gram-Negative Pathogens from New York CityAmabel Lapuebla, Marie Abdallah, Olawole Olafisoye, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2015
Activity of Meropenem Combined with RPX7009, a Novel β-Lactamase Inhibitor, against Gram-Negative Clinical Isolates in New York CityAmabel Lapuebla, Marie Abdallah, Olawole Olafisoye, et al.
Archives of Internal Medicine|June 29, 2005
Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentariumSimona Bratu, David Landman, Robin Haag, et al.
The Journal of Antimicrobial Chemotherapy|May 27, 2005
Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agentsSimona Bratu, Pooja Tolaney, Usha Karumudi, et al.
Infection Control and Hospital Epidemiology|November 19, 2020
Trends in central-line-associated bloodstream infections and catheter-associated urinary tract infections in a large acute-care hospital system in New York City, 2016-2019Monica A Kaminski, Briana Episcopia, Saquib Malik, et al.
The Journal of Antimicrobial Chemotherapy|March 2, 2012
Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustrationDavid Landman, Elizabeth Babu, Neha Shah, et al.
Pageof 6